story of the week
High Tumor Mutation Burden Fails to Predict Immune Checkpoint Blockade Response Across All Cancer Types
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
High Tumor Mutation Burden Fails to Predict Immune Checkpoint Blockade Response Across All Cancer Types
Ann. Oncol 2021 Mar 10;[EPub Ahead of Print], DJ McGrail, PG Pilié, NU Rashid, L Voorwerk, M Slagter, M Kok, E Jonasch, M Khasraw, AB Heimberger, B Lim, NT Ueno, JK Litton, R Ferrarotto, JT Chang, SL Moulder, SY LinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.